Table 2 Comparison between acute HF patients admitted with hsCRP below and above 25 mg/L
Characteristics | hsCRP< 25 mg/L (n = 347) | hsCRP≥25 mg/L (n = 268) | p-value |
|---|---|---|---|
Male sex, n (%) | 144 (41.5) | 134 (50.0) | 0.04 |
Age, mean (SD) | 76 (12) | 77 (12) | 0.53 |
Atrial fibrillation, n (%) | 159 (45.8) | 121 (45.1) | 0.88 |
Diabetes mellitus, n (%) | 149 (42.9) | 104 (38.8) | 0.30 |
Coronary heart disease, n (%) | 143 (41.2) | 108 (40.3) | 0.83 |
Admission NYHA IV (vs II/III) | 207 (59.6) | 164 (61.2) | 0.87 |
Admission heart rate (bpm), mean (SD) | 88 (24) | 89 (23) | 0.58 |
Admission systolic blood pressure (mmHg), mean (SD) | 137 (29) | 130 (29) | 0.01 |
Left ventricular systolic dysfunction, n (%) | 215 (62.0) | 156 (58.2) | 0.22 |
Haemoglobin (mmol/L), mean (SD) | 7.4 (1.3) | 7.1 (1.3) | < 0.001 |
Leukocytes (cells/μL) | 7918 (3172) | 9645 (3972) | < 0.001 |
Neutrophils (cells/μL) | 5861 (2830) | 7534 (3543) | < 0.001 |
Monocyte-to-Lymphocyte Ratio, mean (SD) | 0.53 (0.36) | 0.67 (0.40) | < 0.001 |
Glomerular filtration rate (mL/min/1.73m2) | 48.0 (20.7) | 45.4 (21.0) | 0.13 |
Infectious condition at admission, n (%) | 70 (20.2) | 186 (69.4) | < 0.001 |
BNP (pmol/L), median (IQR) | 446.8 (252.2–797.0) | 549.0 (304.4–848.8) | 0.05 |
Acetylsalicylic acid, n (%) | 167 (48.1) | 126 (47.0) | 0.69 |
Statin, n (%) | 165 (47.6) | 143 (53.4) | 0.19 |
1-year death | 130 (37.5) | 102 (38.1) | 0.88 |